These highlights do not include all the information needed to use ...
Clinical trials of prucalopride tablets for CIC involved 2530 patients, showing common adverse reactions like headache (19%), abdominal pain (16%), and nausea (14%). Diarrhea onset was early, resolving quickly. Discontinuation due to adverse reactions was 5% for prucalopride vs. 3% for placebo. Cardiovascular safety analysis showed no significant MACE risk increase.
Reference News
These highlights do not include all the information needed to use ...
Clinical trials of prucalopride tablets for CIC involved 2530 patients, showing common adverse reactions like headache (19%), abdominal pain (16%), and nausea (14%). Diarrhea onset was early, resolving quickly. Discontinuation due to adverse reactions was 5% for prucalopride vs. 3% for placebo. Cardiovascular safety analysis showed no significant MACE risk increase.